Date
12 July 2018
Novartis drops antibiotic development program
Chris Dall of the Center for Infectious Disease Research and Policy (CIDRAP) quotes Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, on Novartis’ recent announcement to drop its antibacterial and antiviral research programmes.
Direct links
“Novartis leaving innovation in antibiotics is unfortunate, as we still need effective replacement antibiotics, and Novartis has a few in development. They are in discussions to divest them, so hopefully there’s a suitable partner to complete their development.” – Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation.